Financial Management Professionals, Inc. Surface Oncology, Inc. Transaction History

Financial Management Professionals, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	BUY	$0.61 - $1.03 $244 - $412	400 Added 66.67%	1,000 $1,000
Q4 2022 Jan 11, 2023	BUY	$0.62 - $1.21 $62 - $121	100 Added 20.0%	600 $0
Q2 2022 Jul 12, 2022	BUY	$1.42 - $3.15 $710 - $1,575	500 New	500 $1,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Management Professionals, Inc. with notifications on news.